by Will Freyre | Jul 17, 2023 | Current
Burton’s appointment ushers in a bold new era for DRIF, the fundraising arm of the premier cure-based research institute Michael Burton, CEO, Diabetes Research Institute Foundation MIAMI (July 17, 2023) – The Diabetes Research Institute Foundation (DRIF), the...
by Will Freyre | Nov 18, 2022 | Current
Teplizumab, the first drug that can delay the onset of type 1 diabetes, earns FDA approval after undergoing clinical trials at the Diabetes Research Institute The Diabetes Research Institute (DRI), one of the largest and most comprehensive research centers dedicated...
Recent Comments